Adrenocortical Carcinoma Adrenal Tumor - Pipeline Review, Q4 2010

Global Markets Direct, December 2010, Pages: 24

Adrenocortical Carcinoma Adrenal Tumor - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Adrenocortical Carcinoma Adrenal Tumor Pipeline Review, Q4 2010”, provides an overview of the Adrenocortical Carcinoma Adrenal Tumor therapeutic pipeline. This report provides information on the therapeutic development for Adrenocortical Carcinoma Adrenal Tumor , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Adrenocortical Carcinoma Adrenal Tumor . “Adrenocortical Carcinoma Adrenal Tumor -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Adrenocortical Carcinoma Adrenal Tumor   .
- A review of the Adrenocortical Carcinoma Adrenal Tumor    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Adrenocortical Carcinoma Adrenal Tumor    pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- A snapshot of the global therapeutic scenario for Adrenocortical Carcinoma Adrenal Tumor   .
- A review of the Adrenocortical Carcinoma Adrenal Tumor    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Adrenocortical Carcinoma Adrenal Tumor    pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Adrenocortical Carcinoma Adrenal Tumor Overview
Therapeutics Development
An Overview of Pipeline Products for Adrenocortical Carcinoma Adrenal Tumor
Adrenocortical Carcinoma Adrenal Tumor Therapeutics under Development by Companies
Adrenocortical Carcinoma Adrenal Tumor Therapeutics under Investigation by Universities/Institutes
Companies Involved in Adrenocortical Carcinoma Adrenal Tumor Therapeutics Development
Astellas Pharma Inc.
Neotropix, Inc.
Universities/Institutes Involved in Adrenocortical Carcinoma Adrenal Tumor Therapeutics Development
Adrenocortical Carcinoma Adrenal Tumor Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Companies
OSI-906 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Renal Cell Carcinoma (Event Driven)
• Brain Tumor – Pipeline Review, H1 2013
• Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
• Future Horizons in the Global Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country
• Clinical Endocrinology and Metabolism - A Colour Handbook
• Competing in the Global Cancer Diagnostics Market
• 2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
• Future Horizons in the US Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment
• Oncology Intelligence: A Comprehensive Report for Decision Making
• Tumor Markers: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers